Stocks · News reference
Cantor Fitzgerald Maintains Overweight on CVRx, Lowers Price Target to $5
Cantor Fitzgerald analyst Sarah James maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $13 to $5.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 17, 2026, 11:09 AM
- Checked
- Aug 17, 2026, 11:09 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
CVRx Shareholder Urges Board To Launch Sale Process To Unlock Barostim’s Strategic Value
Read original at benzingaCVRx Announces Devoted Health Issued Medicare Advantage Coverage Policy For Barostim Effective July 17
Read original at benzingaCVRx shares are trading lower after Cantor Fitzgerald lowered its price target on the stock from $13 to $5.
Read original at benzinga